Darifenacin Hydrobromide extended Release IP 7.5
Nov 02, 2022
Derifenac 7.5
Darifenacin Hydrobromide extended Release IP 7.5 is used to treat an overactive bladder. By relaxing the muscles in the bladder, Darifenacin Hydrobromide extended Release IP 7.5 improves your ability to control your urination. Darifenacin Hydrobromide extended Release IP 7.5 helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom.
For more information please contact:
Recent Post
Allium Cepa, Heparin Sodium & Allantoin – The Ultimate Skin Repair Formula
PCD Pharma Company in Ahmedabad, Gujarat | Steris Healthcare Pvt Ltd..
Gliempaflozin Met 12.5mg/500mg Tablet | Steris Healthcare Pvt Ltd...
Sitagliptin Phosphate (50mg) & Metformin HCl (500mg) – Uses, Benefits, and Dosage
Magaldrate & Simethicone Oral Suspension in STERIS ANTACID MSO.
Calcium Polystyrene Sulphonate Powder: Mechanism of Action and Side Effects.
Lymecycline Capsules bp 408 mg Tablet From Steris healthcare.
Managing Type 2 Diabetes with Gliclazide (40mg) and Metformin (500mg)
Tolvaptan 15mg: Uses, Dosage, Side Effects, and Benefits
Understanding Repaglinide 0.5mg: A Guide to Managing Type 2 Diabetes